King Rachel K.
SEC insider (Form 3/4/5 filer). CIK 0001589712. Director at Fulcrum Therapeutics, Inc. (FULC) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in CAMBRIDGE, MA.
Companies King Rachel K. has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Director
- NOVAVAX INC (NVAX): Director
King Rachel K.
CIK: 0001589712
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 30, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Jun 20, 2026NVAX
NOVAVAX INC
ExerciseDirect18.9K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
21.3K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
14.2K shares- - Jun 26, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
36K shares- - Jun 20, 2025NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
18.9K shares- - Jun 20, 2025NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
28.3K shares at avg. $6.42- - Jun 12, 2025NVAX
NOVAVAX INC
ExerciseDirect10.4K shares- - Dec 13, 2024NVAX
NOVAVAX INC
SaleDirect4.2K shares at avg. $9.02$37K - Nov 12, 2024FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Jun 20, 2026 |  NVAX NOVAVAX INC | Exercise | 18,880 | - | $0 | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 21,270 | - | - | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Restricted Stock Units | 14,180 | - | - | Direct |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 36,000 | - | - | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award Restricted Stock Units | 18,884 | - | - | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 28,326 | $6.42 | - | Direct |
| Jun 12, 2025 | NVAX NOVAVAX INC | Exercise | 10,420 | - | - | Direct |
| Dec 13, 2024 | NVAX NOVAVAX INC | Sale | 4,150 | $9.02 | $37,435 | Direct |
| Nov 12, 2024 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 60,000 | - | - | Direct |
1-10 of 10 transactions